Department of Biochemistry and Biomedical Sciences, Farncombe Family Digestive Health Research Institute McMaster University, Hamilton, Ontario, L8N 3Z5, Canada.
Departments of Genetics and Medicine, Stanford University, Stanford, CA, 94305, USA.
Mol Metab. 2020 Dec;42:101067. doi: 10.1016/j.molmet.2020.101067. Epub 2020 Aug 26.
Hyperinsulinemia can be both a cause and consequence of obesity and insulin resistance. Hyperinsulinemia can result from increased insulin secretion and/or reduced insulin clearance. While many studies have focused on mechanisms triggering insulin secretion during obesity, the triggers for changes in insulin clearance during obesity are less defined. In this study, we investigated the role of the microbiota in regulating insulin clearance during diet-induced obesity.
Blood glucose and insulin clearance were tested in conventional male mice treated with antibiotics and germ-free mice colonized with microbes from mice that were fed a control (chow) diet or an obesogenic high-fat diet (HFD). The composition of the fecal microbiota was analyzed using 16S rRNA sequencing.
Short-term HFD feeding and aging did not alter insulin clearance in the mice. Oral antibiotics mitigated impaired blood insulin clearance in the mice fed an HFD for 12 weeks or longer. Germ-free mice colonized with microbes from HFD-fed donor mice had impaired insulin but not C-peptide clearance. Microbe-transmissible insulin clearance impairment was only observed in germ-free mice after more than 6 weeks post-colonization upon HFD feeding. Five bacterial taxa predicted >90% of the variance in insulin clearance. Mechanistically, impaired insulin clearance was associated with lower levels of hepatic Ceacam-1 but increased liver and skeletal muscle insulin-degrading enzyme (IDE) activity.
Gut microbes regulate insulin clearance during diet-induced obesity. A small cluster of microbes or their metabolites may be targeted for mitigating defects in insulin clearance and hyperinsulinemia during the progression of obesity and type 2 diabetes.
高胰岛素血症既可以是肥胖和胰岛素抵抗的原因,也可以是其结果。高胰岛素血症可能源于胰岛素分泌增加和/或胰岛素清除减少。虽然许多研究都集中在肥胖期间触发胰岛素分泌的机制上,但肥胖期间胰岛素清除变化的触发因素还不太明确。在这项研究中,我们研究了微生物组在调节饮食诱导肥胖期间胰岛素清除中的作用。
在接受抗生素治疗的常规雄性小鼠和用来自喂食对照(常规)饮食或致肥胖高脂肪饮食(HFD)的小鼠的微生物定植的无菌小鼠中,测试了血糖和胰岛素清除率。使用 16S rRNA 测序分析粪便微生物组的组成。
短期 HFD 喂养和衰老不会改变小鼠的胰岛素清除率。口服抗生素减轻了喂食 HFD 12 周或更长时间的小鼠的胰岛素清除受损。用 HFD 喂养的供体小鼠的微生物定植的无菌小鼠胰岛素清除受损,但 C 肽清除不受影响。只有在无菌小鼠定植后超过 6 周并喂食 HFD 时,才能观察到微生物可传播的胰岛素清除受损。五种细菌类群可预测 90%以上的胰岛素清除率的差异。从机制上讲,胰岛素清除受损与肝 Ceacam-1 水平降低有关,但与肝和骨骼肌胰岛素降解酶(IDE)活性增加有关。
肠道微生物在饮食诱导的肥胖期间调节胰岛素清除。一小簇微生物或其代谢产物可能是针对肥胖和 2 型糖尿病进展期间胰岛素清除缺陷和高胰岛素血症的治疗靶点。